石药集团:盐酸阿姆西汀肠溶片III期临床试验达到主要终点

智通财经
Jul 27
【石药集团:盐酸阿姆西汀肠溶片III期临床试验达到主要终点】石药集团公告,本集团开发的1类创新药盐酸阿姆西汀肠溶片治疗抑郁症患者的III期临床试验已达成预设主要有效性终点,试验结果兼具显著的统计学差异与明确的临床获益。HA1406治疗第8周末蒙哥马利-艾斯伯格抑郁量表评分较基线变化值显著优于安慰剂,且数值上优于阳性对照药,安全性良好,有望成为抑郁症的一线治疗药物。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10